NDA 17346, held by Parke Davis. Heparin Sodium.
As of Nov 13, 2026, NDA 17346 (Heparin Sodium, Heparin Lock Flush), held by Parke Davis, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Heparin Sodium1,000 UNITS/ML · injectable;injection | Heparin Sodium | Discontinued |
| Heparin Sodium5,000 UNITS/ML · injectable;injection | Heparin Sodium | Discontinued |
| Heparin Sodium7,500 UNITS/ML · injectable;injection | Heparin Sodium | Discontinued |
| Heparin Sodium10,000 UNITS/ML · injectable;injection | Heparin Sodium | Discontinued |
| Heparin Sodium20,000 UNITS/ML · injectable;injection | Heparin Sodium | Discontinued |
| Heparin Lock Flush10 UNITS/ML · injectable;injection | Heparin Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
